<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

Apollo Hospitals Enterprise Limited

NSE: APOLLOHOSP · Lot size: 125

Apollo Hospitals Enterprise Limited Open Interest & PCR Analysis

7,752.5Updated 21 Apr 2026, 01:26 pm IST
PCR
0.90
Neutral
Max Pain
7,550
Spot above by ₹203
Total CE OI
881K
Call writers
Total PE OI
789K
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish

Data as of 2026-04-21

Frequently Asked Questions

What is Apollo Hospitals Enterprise Limited PCR (Put-Call Ratio) today?
Apollo Hospitals Enterprise Limited's current PCR is 0.90. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Apollo Hospitals Enterprise Limited's PCR of 0.90 indicates neutral sentiment.
What is Apollo Hospitals Enterprise Limited OI buildup type today?
Apollo Hospitals Enterprise Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Apollo Hospitals Enterprise Limited?
Apollo Hospitals Enterprise Limited has total CE (call) OI of 880500 contracts and total PE (put) OI of 788500 contracts for the nearest expiry. The PCR is 0.90.
How is open interest analysis useful for Apollo Hospitals Enterprise Limited trading?
OI analysis for Apollo Hospitals Enterprise Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Apollo Hospitals Enterprise Limited?
Apollo Hospitals Enterprise Limited's max pain is ₹7,550 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.